SCHEMBL8400243

SCHEMBL8400243

CC1CC=C(c2nnn(C)n2)CN1C

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8405154 0.82 CHRM2 (0.36) CHRM2CHRM3
SCHEMBL8400773 0.74 CHRM2 (0.36) CHRM2CHRM3
SCHEMBL8400767 0.72 CHRM2 (0.37) CHRM2CHRM3
SCHEMBL8400245 0.70 CHRM2 (0.68) CHRM2CHRM3
SCHEMBL14593145 0.62
SCHEMBL6913448 0.58 CHRM1 (0.49)
SCHEMBL13846198 0.56 NPC1 (0.48)
SCHEMBL14593128 0.56 GABRR1 (0.35)
SCHEMBL16022252 0.55 LMNA (0.59)
SCHEMBL22322481 0.55 USP2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36374-E 1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists H. LUNDBECK, A/S (DK) 1999-11-02 US disclosed
EP-0296721-B1 HETEROCYCLIC COMPOUNDS H. LUNDBECK A/S (DK) 1993-06-23 EP disclosed
US-4925858-A NERVOUS SYSTEM DISORDERS, ALZHEIMER*S DISEASE H. LUNDBECK A/S (DK) 1990-05-15 US disclosed
US-4866077-A TREATMENT OF NERVOUS SYSTEM DISORDERS SUCH AS ALZHEIMER*S DISEASE H. LUNDBECK A/S (DK) 1989-09-12 US disclosed
EP-0296721-A2 Heterocyclic compounds H. LUNDBECK A/S (DK) 1988-12-28 EP disclosed